Elsevier

The Lancet

Volume 329, Issue 8534, 21 March 1987, Pages 659-661
The Lancet

EVIDENCE THAT THE GENE FOR TUBEROUS SCLEROSIS IS ON CHROMOSOME 9

https://doi.org/10.1016/S0140-6736(87)90416-8Get rights and content

Abstract

Linkage analysis was undertaken in nineteen families with tuberous sclerosis by use of 26 polymorphic markers. All affected members fulfilled strict diagnostic criteria and unaffected members were rigorously investigated to confirm their status. Maximum lod scores were 1·20 for adenylate kinase 1 (AK1) at zero recombination and 3·85 for the ABO blood group at zero recombination (confidence limits 0-0·10). These findings support the assignment of the gene for tuberous sclerosis to the distal long arm of chromosome 9.

References (14)

  • Fa Flinter et al.

    Examining the parents of children with tuberous sclerosis

    Lancet

    (1986)
  • Jm Connor et al.

    Non-penetrance in tuberous sclerosis

    Lancet

    (1986)
  • A. Hunt et al.

    Tuberous sclerosis; a new estimate of prevalence within the Oxford region

    J Med Genet

    (1984)
  • MR. Gomez

    Tuberous sclerosis

    (1979)
  • Jc Alper et al.

    The incidence and significance of birthmarks in a cohort of 4641 newborns

    Pediatr Dermatol

    (1983)
  • Gm Farrow et al.

    Renal angiomyolipoma: A clinicopathologic study of 32 cases

    Cancer

    (1968)
There are more references available in the full text version of this article.

Cited by (340)

  • Renal organoid modeling of tuberous sclerosis complex reveals lesion features arise from diverse developmental processes

    2022, Cell Reports
    Citation Excerpt :

    Tuberous sclerosis complex (TSC) is a monogenic multisystem disorder characterized by tumor formations in multiple organ systems (Henske et al., 2016; Salussolia et al., 2019). The genetic etiology is biallelic inactivating mutations in either TSC1 or TSC2 (European Chromosome 16 Tuberous Sclerosis Consortium, 1993; Fryer et al., 1987; Slegtenhorst et al., 1997), canonically leading to hyperactive mTORC1 signaling (Huang and Manning, 2008). Kidney lesions affect approximately 60% to 80% of patients with TSC (Casper et al., 2002; Cook et al., 1996; O’Callaghan et al., 2004; Rakowski et al., 2006) and are the leading cause of mortality (Amin et al., 2017; Shepherd et al., 1991).

  • Genetic pathogenesis of the epileptogenic lesions in Tuberous Sclerosis Complex: Therapeutic targeting of the mTOR pathway

    2022, Epilepsy and Behavior
    Citation Excerpt :

    TSC1 and TSC2 are two tumor suppressor genes encoding hamartin and tuberin, respectively [4,5]. Evidence of the linkage of TSC to a gene (TSC1) located on chromosome 9q34 has been provided in 1987 [10]. The TSC1 gene contains 23 exons with 21 exons coding for an 8.6 kb transcript which is translated into the protein product hamartin.

  • Tuberous sclerosis complex

    2020, Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease: Volume 2
View all citing articles on Scopus
View full text